Pharma - Industry – Focus

 

Custom Search

Bulk Drug Manufacturing

Prudence Pharma Chem to set up bulk drug unit at Ankleshwar


Prudence Pharma Chem  to set up bulk drug unit at Ankleshwar  in Bharuch district of Gujarat with an investment of Rs. 11.7 million. . It is proposed to stop the existing products and to manufacture various other bulk drugs and intermediates with installed capacity of 10 MTPM within the same premises.  Besides 12 MTPM of Bulk Intermediates and by-products will be manufactured.

Details of products along with their production capacity are given below:

 

Sr.

No.

Name of Products

Chemical Name of Product

Capacity, MT/Month

Group A

A-1.

Losarton Potassium (LSR)

(2-n-butyl-4-chloro-5-hydroxy-methyl-1-[(2`-(1H-tetrazol-5-yl potassium 

OR
2-n-Butyl-4-Chloro-l[{(2`-tetrazol-5-
yl)-l,l`-bisphenyl-4-yl}methyl]-imidazole-5-methanol potassium 

OR

[1- {2`- (2H-tetrazol-5-yl) biphenyl -4-yl}methyl]-2-butyl-4-chloro-1H-imidazol -5-yl) methanol potassium

3.0

A-2.

Metaxalone (MX)

5-[(3,5-dimethylphenoxy)methyl]oxazolidin-2-one

OR

5-(3,5-Dimethyl Phenoxy methyl)-2-oxazolidinone

A-3.

Amlodipine Besylate (AMB)

3-Ethyl 5-methyl (4RS)-2-[(2-aminoethoxy) methyl]-4-(2-chlorophenyl)-6-methyl-1, 4-dihydropyridine-3, 5-dicarboxylate benzenesulphonate.

Group B

B-1.

Glibenclamide (GLB)

1-[{4-(2-[(5-Chloro-2-ethoxybenzoyl) amino] ethyl) phenyl} sulphonyl]-3-cyclohexylurea.

7.0

B-2.

Niclosamide

5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide

Total Capacity (Group A + B)

10.0

 

List of Intermediate Products

Sr. No.

Production Stage

Chemical Name of

Intermediate product

Kg/Kg of Finished product

Capacity, MT/Month

Group A

A-1

Stage  1 (LSR -1)

3-Butyl-4-chloro 5-methyl hydroxy N-(4-methyl 2-cyno biphenyl) imidazole

1.25

3.75

Stage  2 (LSR -2)

3-Butyl-4-chloro 5-methyl hydroxy N-(4-methyl 2-1 H tetrazole biphenyl) imidazole

1.00

3.00

A-2

Stage -1 (MX- 1)

2-[(3,5-dimethylphenoxy)methyl]oxirane

2.32

6.96

Stage -2 (MX- 2)

1-amino-2-(3,5-dimethylphenoxy)ethanol

1.67

5.01

A-3

Stage -1 (AMB- 1)

Hydroxy ethyl Phthlamide

[HEP ]

1.35

4.05

Stage -2 (AMB- 2)

Methy 3 Amino Crotonate [MAC]

2.00

6.00

Stage -3 (AMB- 3)

Ethyl -4-(2-Phthlamide) ethyl aceto acetate. [PHEMA] & Phthloyal Amlodipine

1.50

4.50

Stage -4 (AMB- 4)

Amlodipine Base

1.00

3.00

B-4

Stage -2 (GLB  2)

Sulphonamide

0.72

5.04

 

Maximum Capacity

Group A

 

6.96

Group B

 

5.04

 

 

Total Capacity (Group A + B)

 

12.00

 

*    The unit may sale intermediate products at any stage as stated above from the     manufacturing of each product.

*   The maximum production capacity of intermediate products will not exceed 12.00 MT/Month

List of By-Products

Sr. No.

Source

Name Of The Byproducts

Capacity, MT/Month

GROUP A

1.

APCE for Metaxalone (A -2 )

Liquid Ammonia

150.00

GROUP - B

1.

APCE for Glibenclamide (A -2 )

HCl Solution

6.70

Sodium bi Sulphite

9.80

2.

APCE for Niclosamide (A -2 )

HCl Solution

3.00

Sodium bi Sulphite

4.40    

 

 

 

 

 

Maximum Capacity

Liquid Ammonia

150.00

HCl Solution

6.70

Sodium bi Sulphite

9.80

 

Alembic to expand its drug unit at Vadodara

 

Alembic to expand its drug unit at Vadodara in Gujarat with an investment of Rs. 2690 million. The project involves expanding  Penicillin G- manufacturing unit from 83.33 MMU to 240 MMU

Details of products and with their production capacities are given below:

 

SR. NO.

NAME OF PRODUCT

CAPACITY

(PER MONTH)

EXISTING

TOTAL AFTER PROPOSED EXPANSION

  1.  

Penicillin  G

83.33 MMU

240 MMU

  1.  

Erythromycin (Thio)

10.5 T

10.5 T

  1.  

Erythromycin Estolate

7.4 T

7.4 T

  1.  

Protinules Powder

20  T

-

  1.  

Tablets and capsules

150 lacs Tablet &                                                                                   5  lacs Capsules

-

  1.  

Injectables (dry powder)

10 T

-

  1.  

Liquid oral preparations

16 lacs unit

-

  1.  

Roxithromycin

5  T

5 T

  1.  

Cephalosporin - C      

10  T

10 T

  1.  

Sod. Penicillin G

12 MMU

12 MMU

  1.  

Benzathine Penicillin G

2.5 T

2.5 T

  1.  

Procaine Penicillin G

14.5 MMU

14.5 MMU

  1.  

Sterile Azithromycin

200 kg

-

  1.  

Dried Yeast Powder

9.85 T

9.85 T

  1.  

Rofecoxib

360 Kg

360 Kg

  1.  

Pioglitazon HCL

15 Kg

15 Kg

  1.  

Mosapride Citrate

15 Kg

15 Kg

  1.  

Meloxicam

48 Kg

48 Kg

Note : 1 MMU Penicillin = 1000 BU = Approx. 640 Kg.

 

Production of product no. 4 to 7 & 13 already stopped since 2003              

Surya Drugs & Pharmaceuticals to expand it bulk drug unit at Ankleshwar


 Surya Drugs & Pharmaceuticals  to expand it bulk drug unit at Ankleshwar in Bharuch district of Gujarat with an investment of Rs. 5.0 million. The project involves expanding  bulk drugs & fine chemicals manufacturing unit from 5 MTPM to 50 MTPM.

.         Details of products and their  production capacities are given below:

    

Sr. No.

Product

Capacity (MTPM)

Existing

1

2:4:5 Tri Chloro Nitro Benzene

2

2

Spent Sulphuric Acid

3

Proposed

1

Gabapentine HCl

30

2

Glimipiride HCl

25

3

Lamotrigine

30

4

Lidocaine HCl

15

5

Phenyl Propyl Amine HCl

25

6

Quinine Sulphate

3

7

Terbutaline Sulphate

20

8

Venlafexine HCl

15

9

Para Anisyl Alcohol

50

10

Salbutamol Sulphate

5

11

Meta Phenoxy Benzyl Alcohol

30

12

Phenanthrene

20

13

Oxcarbazepine

20

14

Meta Bromo Anisol

20

15

Sucralfate

30

 

* The unit proposes to manufacture 50 MT/month any of the above product individually  or combination from any above product.

JNP Products to expand its bulk drug unit at Jhagadia in Bharuch


JNP Products to expand its bulk drug unit at Jhagadia in Bharuch district of Gujarat with an investment of Rs. 150 million. Presently the unit is manufacturing 4 Amino Phenol (PAP Slurry) at a production capacity of 500 MTPM which is used for manufacturing paracetamol. After expansion, production capacity will increase to  1650 MTPM. The land available with the company is 26000 m2. Expansion will be carried within the existing unit.

Custom Search

Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony
Guduvancherry, Chennai -603 202   Mobile : 0-97898-37940 email : [email protected] Privacy Policy